Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 93

    1.

    Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.

    Huynh E, Sigal D, Saven A.

    Leuk Lymphoma. 2009 Oct;50 Suppl 1:12-7.PMID: 19814692 [PubMed - in process]Related articles

    2.

    Purification and characterization of sideroblasts from patients with acquired and hereditary sideroblastic anaemia.

    Martin FM, Prchal J, Nieva J, Saven A, Andrey J, Bethel K, Barton JC, Aripally G, Bottomley SS, Friedman JS.

    Br J Haematol. 2008 Nov;143(3):446-50. Epub 2008 Aug 20. No abstract available. PMID: 18729851 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo.

    Hassig CA, Symons KT, Guo X, Nguyen PM, Annable T, Wash PL, Payne JE, Jenkins DA, Bonnefous C, Trotter C, Wang Y, Anzola JV, Milkova EL, Hoffman TZ, Dozier SJ, Wiley BM, Saven A, Malecha JW, Davis RL, Muhammad J, Shiau AK, Noble SA, Rao TS, Smith ND, Hager JH.

    Mol Cancer Ther. 2008 May;7(5):1054-65.PMID: 18483295 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cladribine in indolent non-Hodgkin's lymphoma.

    Sigal DS, Saven A.

    Expert Rev Anticancer Ther. 2008 Apr;8(4):535-45. Review.PMID: 18402520 [PubMed - indexed for MEDLINE]Related articles

    5.

    Hairy cell leukemia.

    Fanta PT, Saven A.

    Cancer Treat Res. 2008;142:193-209. Review.PMID: 18283787 [PubMed - indexed for MEDLINE]Related articles

    6.

    Understanding hairy cell leukemia genetics.

    Nieva J, Saven A.

    Leuk Lymphoma. 2007 Apr;48(4):653-4. No abstract available. PMID: 17454620 [PubMed - indexed for MEDLINE]Related articles

    7.

    How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma?

    Diamond C, Taylor TH, Im T, Wallace M, Saven A, Anton-Culver H.

    Cancer Causes Control. 2007 Mar;18(2):135-42. Epub 2007 Jan 18.PMID: 17235495 [PubMed - indexed for MEDLINE]Related articles

    8.

    Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153.

    Blum KA, Johnson JL, Niedzwiecki D, Piro LD, Saven A, Peterson BA, Byrd JC, Cheson BD; Cancer and Leukemia Group B Study 9153.

    Cancer. 2006 Dec 15;107(12):2817-25.PMID: 17120198 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Use of optophoresis as an in vitro predictor of cell response to chemotherapy for chronic lymphocytic leukemia.

    Nerenberg M, Kariv I, McNeeley P, Marchand P, Sur S, Diver J, Riccitelli S, Nieva J, Saven A.

    Leuk Lymphoma. 2006 Oct;47(10):2194-202.PMID: 17071495 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cladribine in hairy cell leukemia.

    Belani R, Saven A.

    Hematol Oncol Clin North Am. 2006 Oct;20(5):1109-23. Review.PMID: 16990111 [PubMed - indexed for MEDLINE]Related articles

    11.

    Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation.

    McWhirter JR, Kretz-Rommel A, Saven A, Maruyama T, Potter KN, Mockridge CI, Ravey EP, Qin F, Bowdish KS.

    Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1041-6. Epub 2006 Jan 17.PMID: 16418292 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Reactive thrombocytosis associated with a pheochromocytoma.

    Bazhenova L, Du EZ, Bhoyrul S, McCallum J, Saven A.

    Thromb Haemost. 2005 Aug;94(2):460-2. No abstract available. PMID: 16113840 [PubMed - indexed for MEDLINE]Related articles

    13.

    SHP1 expression in bone marrow biopsies of myelodysplastic syndrome patients: a new prognostic factor.

    Mena-Duran AV, Togo SH, Bazhenova L, Cervera J, Bethel K, Senent ML, Nieva J, Sanz GF, Sanz MA, Saven A, Mustelin T.

    Br J Haematol. 2005 Jun;129(6):791-4.PMID: 15953006 [PubMed - indexed for MEDLINE]Related articles

    14.

    Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis.

    Felding-Habermann B, Lerner RA, Lillo A, Zhuang S, Weber MR, Arrues S, Gao C, Mao S, Saven A, Janda KD.

    Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17210-5. Epub 2004 Nov 24.PMID: 15563590 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Cladribine: from the bench to the bedside--focus on hairy cell leukemia.

    Greyz N, Saven A.

    Expert Rev Anticancer Ther. 2004 Oct;4(5):745-57. Review.PMID: 15485311 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cladribine activity in systemic mast cell disease: application of biochemistry in the modern era of molecular biology.

    Nieva J, Saven A.

    Leuk Res. 2004 Feb;28(2):113-4. Review. No abstract available. PMID: 14654073 [PubMed - indexed for MEDLINE]Related articles

    17.

    CD52 expression in hairy cell leukemia.

    Quigley MM, Bethel KJ, Sharpe RW, Saven A.

    Am J Hematol. 2003 Dec;74(4):227-30.PMID: 14635201 [PubMed - indexed for MEDLINE]Related articles

    18.

    Evidence for ozone formation in human atherosclerotic arteries.

    Wentworth P Jr, Nieva J, Takeuchi C, Galve R, Wentworth AD, Dilley RB, DeLaria GA, Saven A, Babior BM, Janda KD, Eschenmoser A, Lerner RA.

    Science. 2003 Nov 7;302(5647):1053-6.PMID: 14605372 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: results of a phase II study.

    Gregory SA, Case DC Jr, Bosserman L, Litwak DL, Berry WR, Kalman LA, Belt RJ, Saven A.

    Clin Lymphoma. 2003 Sep;4(2):93-8.PMID: 14556680 [PubMed - indexed for MEDLINE]Related articles

    20.

    Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.

    Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B.

    Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9482-7. Epub 2003 Jul 21.PMID: 12874388 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Hairy cell leukemia: an update.

    Goodman GR, Bethel KJ, Saven A.

    Curr Opin Hematol. 2003 Jul;10(4):258-66. Review.PMID: 12799530 [PubMed - indexed for MEDLINE]Related articles

    22.

    Cladribine in the treatment of hairy-cell leukaemia.

    Goodman GR, Beutler E, Saven A.

    Best Pract Res Clin Haematol. 2003 Mar;16(1):101-16. Review.PMID: 12670469 [PubMed - indexed for MEDLINE]Related articles

    23.

    Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.

    Nieva J, Bethel K, Saven A.

    Blood. 2003 Aug 1;102(3):810-3. Epub 2003 Mar 27.PMID: 12663446 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.

    Goodman GR, Burian C, Koziol JA, Saven A.

    J Clin Oncol. 2003 Mar 1;21(5):891-6.PMID: 12610190 [PubMed - indexed for MEDLINE]Related articles

    25.

    A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.

    Byrd JC, Peterson B, Piro L, Saven A, Vardiman JW, Larson RA, Schiffer C.

    Leukemia. 2003 Feb;17(2):323-7.PMID: 12592330 [PubMed - indexed for MEDLINE]Related articles

    26.

    Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

    Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, Schiffer CA, Talpaz M, Guilhot F, Deininger MW, Fischer T, O'Brien SG, Stone RM, Gambacorti-Passerini CB, Russell NH, Reiffers JJ, Shea TC, Chapuis B, Coutre S, Tura S, Morra E, Larson RA, Saven A, Peschel C, Gratwohl A, Mandelli F, Ben-Am M, Gathmann I, Capdeville R, Paquette RL, Druker BJ.

    Blood. 2002 May 15;99(10):3530-9.PMID: 11986204 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Treatment of hairy-cell leukemia.

    Saven A.

    N Engl J Med. 2001 Nov 15;345(20):1500-1. No abstract available. PMID: 11794207 [PubMed - indexed for MEDLINE]Related articles

    28.

    Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer.

    Smith RE Jr, Jaiyesimi IA, Meza LA, Tchekmedyian NS, Chan D, Griffith H, Brosman S, Bukowski R, Murdoch M, Rarick M, Saven A, Colowick AB, Fleishman A, Gayko U, Glaspy J.

    Br J Cancer. 2001 Apr;84 Suppl 1:24-30.PMID: 11308271 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy.

    Glaspy J, Jadeja JS, Justice G, Kessler J, Richards D, Schwartzberg L, Rigas J, Kuter D, Harmon D, Prow D, Demetri G, Gordon D, Arseneau J, Saven A, Hynes H, Boccia R, O'Byrne J, Colowick AB.

    Br J Cancer. 2001 Apr;84 Suppl 1:17-23.PMID: 11308270 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Therapeutic advances in the treatment of hairy cell leukemia.

    Andrey J, Saven A.

    Leuk Res. 2001 May;25(5):361-8. Review. No abstract available. PMID: 11301103 [PubMed - indexed for MEDLINE]Related articles

    31.

    Integrin activation controls metastasis in human breast cancer.

    Felding-Habermann B, O'Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH, Hughes PE, Pampori N, Shattil SJ, Saven A, Mueller BM.

    Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1853-8.PMID: 11172040 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    An open-label pilot trial of cladibrine (2-cholordeoxyadenosine) in patients with primary sclerosing cholangitis.

    Duchini A, Younossi ZM, Saven A, Bordin GM, Knowles HJ, Pockros PJ.

    J Clin Gastroenterol. 2000 Dec;31(4):292-6.PMID: 11129269 [PubMed - indexed for MEDLINE]Related articles

    33.

    Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenström macroglobulinemia.

    Tetreault SA, Saven A.

    Leuk Lymphoma. 2000 Mar;37(1-2):125-30.PMID: 10721776 [PubMed - indexed for MEDLINE]Related articles

    34.

    Treatment of hairy cell leukemia-variant with cladribine.

    Tetreault SA, Robbins BA, Saven A.

    Leuk Lymphoma. 1999 Oct;35(3-4):347-54.PMID: 10706459 [PubMed - indexed for MEDLINE]Related articles

    35.

    Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma.

    Piro LD, White CA, Grillo-López AJ, Janakiraman N, Saven A, Beck TM, Varns C, Shuey S, Czuczman M, Lynch JW, Kolitz JE, Jain V.

    Ann Oncol. 1999 Jun;10(6):655-61.PMID: 10442187 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Cladribine activity in adult langerhans-cell histiocytosis.

    Saven A, Burian C.

    Blood. 1999 Jun 15;93(12):4125-30.PMID: 10361109 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Filgrastim for cladribine-induced neutropenic fever in patients with hairy cell leukemia.

    Saven A, Burian C, Adusumalli J, Koziol JA.

    Blood. 1999 Apr 15;93(8):2471-7.PMID: 10194424 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Mastocytosis: diverse presentations and outcomes.

    Pauls JD, Brems J, Pockros PJ, Saven A, Wagner RL, Weber R, Metcalfe D, Christiansen SC.

    Arch Intern Med. 1999 Feb 22;159(4):401-5.PMID: 10030315 [PubMed - indexed for MEDLINE]Related articles

    39.

    Bolus administration of cladribine in the treatment of Waldenström macroglobulinaemia.

    Liu ES, Burian C, Miller WE, Saven A.

    Br J Haematol. 1998 Dec;103(3):690-5.PMID: 9858218 [PubMed - indexed for MEDLINE]Related articles

    40.

    Long-term follow-up of patients with hairy cell leukemia after cladribine treatment.

    Saven A, Burian C, Koziol JA, Piro LD.

    Blood. 1998 Sep 15;92(6):1918-26.PMID: 9731048 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Splenectomy for hairy cell leukemia in pregnancy.

    Stiles GM, Stanco LM, Saven A, Hoffmann KD.

    J Perinatol. 1998 May-Jun;18(3):200-1. Review.PMID: 9659649 [PubMed - indexed for MEDLINE]Related articles

    42.

    Peripheral T-cell lymphoma after anti-CD20 antibody therapy.

    Tetreault S, Abler SL, Robbins B, Saven A.

    J Clin Oncol. 1998 Apr;16(4):1635-7. No abstract available. Erratum in: J Clin Oncol 1998 May;16(5):2001. PMID: 9552080 [PubMed - indexed for MEDLINE]Related articles

    43.

    2-chlorodeoxyadenosine administration to patients with the myeloid blast phase of chronic myelogenous leukemia.

    Gollard R, Miller WE, Piro LD, Saven A.

    Leuk Lymphoma. 1997 Dec;28(1-2):183-5.PMID: 9498718 [PubMed - indexed for MEDLINE]Related articles

    44.

    Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemia.

    Saven A, Lee T, Schlutz M, Jacobs A, Ellison D, Longmire R, Piro L.

    J Clin Oncol. 1997 Jan;15(1):37-43.PMID: 8996122 [PubMed - indexed for MEDLINE]Related articles

    45.

    Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies.

    Meisenberg BR, Miller WE, McMillan R, Callaghan M, Sloan C, Brehm T, Kosty MP, Kroener J, Longmire R, Saven A, Piro LD.

    J Clin Oncol. 1997 Jan;15(1):11-7.PMID: 8996119 [PubMed - indexed for MEDLINE]Related articles

    46.

    2-Chlorodeoxyadenosine: a potent antimetabolite with major activity in the treatment of indolent lymphoproliferative disorders.

    Saven A, Piro LD.

    Hematol Cell Ther. 1996 Dec;38 Suppl 2:S93-101. Review.PMID: 9137962 [PubMed - indexed for MEDLINE]Related articles

    47.

    Prolonged, complete remission after 2-chlorodeoxyadenosine therapy in a patient with refractory essential mixed cryoglobulinemia.

    Lee TC, Miller WE, Curd JG, Piro LD, Saven A.

    Mayo Clin Proc. 1996 Oct;71(10):966-8.PMID: 8820771 [PubMed - indexed for MEDLINE]Related articles

    48.

    Fludarabine treatment and transfusion-associated graft-versus-host disease.

    Saven A.

    Lancet. 1996 Aug 17;348(9025):473. No abstract available. PMID: 8709797 [PubMed - indexed for MEDLINE]Related articles

    49.

    Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphoma.

    Saven A, Lee T, Kosty M, Piro L.

    J Clin Oncol. 1996 Jul;14(7):2139-44.PMID: 8683247 [PubMed - indexed for MEDLINE]Related articles

    50.

    New perspectives on the approach to chronic lymphocytic leukemia.

    Goodman MG, Spinosa JC, Saven A, Piro LD, Wormsley S.

    Leuk Lymphoma. 1996 Jun;22(1-2):1-10. Review.PMID: 8724523 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...